The stimulant higenamine in weight loss and sports supplements

References

• Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373:1531–1540.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Travis JC, Keizers PHJ, et al. Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol. 2018;56:421–426.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Avula B, Venhuis B, et al. Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA. Drug Test Anal. 2017;9:135–142.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Maller G, DeSouza R, et al. Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014;312:1691–1693.
   PubMed Web of Science ®Google Scholar
• Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA. 2017;318:2004–2010.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Attipoe S, Travis J, et al. Caffeine content of dietary supplements consumed on military bases. JAMA Intern Med. 2013;173:592–594.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Wang Y-H, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8:357–369.
   PubMed Web of Science ®Google Scholar
• Calvert R, Vohra S, Ferguson M, et al. A beating heart cell model to predict cardiotoxicity: effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine. Food Chem Toxicol. 2015;78:207–213.
   PubMed Web of Science ®Google Scholar
• Liu XJ, Wagner HN, Tao S. Measurement of effects of the Chinese herbal medicine higenamine on left ventricular function using a cardiac probe. Eur J Nucl Med. 1983;8:233–236.
   PubMedGoogle Scholar
• Feng S, Jiang J, Hu P, et al. A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects. Acta Pharmacol Sin. 2012;33:1353–1358.
   PubMed Web of Science ®Google Scholar
• Bao Y, Yu G, Xu J, et al. Effect of acute higenamine administration on bradyarrhythmias and His bundle. A clinical study of 14 cases and an animal experiment on dogs. Chin Med J. 1982;95:781–784.
   PubMed Web of Science ®Google Scholar
• Bai G, Yang Y, Shi Q, et al. Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist. Acta Pharmacol Sin. 2008;29:1187–1194.
   PubMed Web of Science ®Google Scholar
• Tsukiyama M, Ueki T, Yasuda Y, et al. ß2-adrenoceptor-mediated tracheal relaxation induced by higenamine from Nandina domestica Thunberg. Planta Med. 2009;75:1393–1399.
   PubMed Web of Science ®Google Scholar
• Grucza K, Kwiatkowska D, Kowalczyk K, et al. Analysis for higenamine in urine by means of ultra-high-performance liquid chromatography-tandem mass spectrometry: interpretation of results. Drug Test Anal 2018;10:1017–1024.
   PubMed Web of Science ®Google Scholar
• U.S. Anti-Doping Agency. U.S. weightlifting athlete Kaitlyn Jarrett accepts sanction for anti-doping rule violation; 2018 Mar 23 [cited 2018 May 18]. Available from: https://www.usada.org/kaitlyn-jarrett-accepts-doping-sanction/
   Google Scholar
• U.S. Anti-Doping Agency. U.S. weightlifting athlete, Carlee Acevedo-Fuller, accepts sanction for anti-doping rule violation; 2017 Aug 16 [cited 2018 May 18]. Available from: https://www.usada.org/carlee-acevedo-fuller-accepts-doping-sanction/
   Google Scholar
• Chang KC, Yun-Choi HS, Lim JK, et al. Synthesis of higenamine, a cardiotonic principle of aconite root. Arch Pharm Res. 1984;7:133–136.
   Google Scholar
• Shen L, Yang X, Yang B, et al. Novel hybrids from lamellarin D and combretastatin A 4 as cytotoxic agents. Eur J Med Chem. 2010;45:11–18.
   PubMed Web of Science ®Google Scholar
• Miousse IR, Skinner CM, Lin H, et al. Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains. Food Chem Toxicol. 2017;109:194–209.
   PubMed Web of Science ®Google Scholar
• Stajić A, Anđelković M, Dikić N, et al. Determination of higenamine in dietary supplements by UHPLC/MS/MS method. J Pharm Biomed Anal. 2017;146:48–52.
   PubMed Web of Science ®Google Scholar
• Bao X, Xu J, Xu Y, et al. [Clinical efficacy of higenamine (Fuzi One) on bradyarrhythmia and study of its mechanism of action on cardiac conduction system with His bundle electrocardiogram]. Shanghai Med J. 1979;2:770–773. Mandarin.
   Google Scholar
• Guo S, Chen K, Qian Z, et al. [Clinical efficacy study of intravenous infusion therapy of higenamine combined with Shengmai injection on bradyarrhythmia in 18 cases]. Beijing Med J. 1981;3:46–47. Mandarin.
   Google Scholar
• Chen FH, Jiang W, Zeng G. [Clinical electrophysiology study of the effects of higenamine (Fuzi One) on sick sinus syndrome]. Chin J Integr Trad West Med. 1984;4:30–31. Mandarin.
   Google Scholar
• Jiang W, Liu X, Tao S, et al. [Clinical study of higenamine (Fuzi One)]. Chin J Integr Trad West Med 1981;1:6–8. Mandarin.
   Google Scholar
• Cao Y, Wang Z, Wang F, et al. [Influence of higenamine hydrochloride myocardial stress test on heart rate, blood pressure, myocardial oxygen consumption]. Chin Hosp Pharm J 2012;32:1353–1355. Mandarin.
   Google Scholar
• Jiang W, Tao S, Li J, et al. [Effects of acute administration of higenamine on bradyarrhythmias: a preliminary clinical study]. Chin J Cardio. 1980;8:95–98. Mandarin.
   Google Scholar
• Du Y, Li F, Xu R, et al. [Tolerability of higenamine hydrochloride in healthy volunteers]. Chin J Clin Pharmacol. 2007;23:258–260. Mandarin.
   Google Scholar
• Du Y, Li F, Wang Q, et al. [Efficacy and safety of a novel pharmacological stress test agent – higenamine in radionuclide myocardial perfusion imaging: phase II clinical trial]. Chin J Nucl Med Mol Imaging. 2014;34:34–38. Mandarin.
   Google Scholar
• Cao Y, Wang Z, Wang F, et al. [Detection of coronary heart disease with 99mTc-MIBI myocardial perfusion imaging stressed by intravenous infusion of higenamine hydrochloride]. Chin J Nucl Med Mol Imaging. 2012;32:203–205. Mandarin.
   Google Scholar
• Zhou W, Wang F, Zhang L, et al. [Myocardial perfusion imaging with higenamine hydrochloride stress studies in diagnosis of coronary artery disease]. Chin J Nucl Med Mol Imaging. 2012;32:408–412. Mandarin.
   Google Scholar
• Feng S, Hu P, Jiang J. Determination of higenamine in human plasma and urine using liquid chromatography coupled to positive electrospray ionization tandem mass spectrometry. J Chromatogr B. 2011;879:763–768.
   PubMedGoogle Scholar
• Tian R, Wang Q, Mi Hz, et al. [Efficacy and safety of higenamine hydrochloride injection used in pharmacological stress myocardial perfusion imaging]. Chin J Clin Pharmacol. 2012;28:88–90. Mandarin.
   Google Scholar
• Sun Y, Hou P. [Hydrochloric acid higenamine load 99mTc-MIBI myocardial perfusion imaging in the diagnosis of coronary artery disease]. Chin Health Stad Management. 2015;6:67–68. Mandarin.
   Google Scholar
• Mi H, Wang Q, Tian R, et al. [The clinical availability of hydrochloric acid higenamine as a stress medicine in radionuclide myocardial perfusion imaging to diagnose coronary artery disease]. J Cardiovasc Pulm Dis. 2015;34:486–488. Mandarin.
   Google Scholar
• Okano M, Sato M, Kageyama S. Determination of higenamine and coclaurine levels in human urine after the administration of a throat lozenge containing Nandina domestica fruit. Drug Test Anal. 2017;9:1788–1793.
   PubMed Web of Science ®Google Scholar
• Towa Pharmaceutical Company. Medication guides: Tosmerian Tablets; 2009 July [cited 2018 June 4]. Available from: http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=36115
   Google Scholar
• Lee SR, Schriefer JM, Gunnels TA, et al. Acute oral intake of a higenamine-based dietary supplement increases circulating free fatty acids and energy expenditure in human subjects. Lipids Health Dis. 2013;12:148.
   PubMed Web of Science ®Google Scholar
• Bloomer RJ, Schriefer JM, Gunnels TA. Clinical safety assessment of oral higenamine supplementation in healthy, young men. Hum Exp Toxicol. 2015;34:935–945.
   PubMed Web of Science ®Google Scholar
• Jeter J, DeZee KJ, Kennedy L. A case of paraspinal muscle rhabdomyolysis in a 22-year-old male after ingesting a supplement containing higenamine. Mil Med. 2015;180:e847.
   PubMed Web of Science ®Google Scholar
• U.S. Anti-Doping Agency. U.S. weightlifting athlete Lazaro Roman accepts sanction for anti-doping rule violation; 2018 Mar 9 [cited 2018 May 18]. Available from: https://www.usada.org/lazaro-roman-accepts-doping-sanction/
   Google Scholar
• U.S. Anti-Doping Agency. U.S. weightlifting athlete Teresa Britt accepts sanction for anti-doping rule violation; 2018 Apr 9 [cited 2018 May 18]. Available from: https://www.usada.org/teresa-britt-accepts-doping-sanction/
   Google Scholar
• Dietary Supplement Health and Education Act of 1994. Pub L No. 103-417, 1994. 103rd Congress, 2nd sess., S784.
   Google Scholar
• U.S. Food and Drug Administration. Dietary supplements: new dietary ingredient notifications and related issues: guidance for industry, 2016 Aug. Available from: https://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/dietarysupplements/ucm257563.htm
   Google Scholar
• Attipoe S, Cohen PA, Eichner A, et al. Variability of stimulant levels in nine sports supplements over a 9-month period. Int J Sport Nutr Exerc Metab. 2016;26:413–420.
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Dietary Supplement Label Database. Version 7.0.2. 2018 Jun [cited 2018 June 27]; Rev 2557. Available from: https://www.dsld.nlm.nih.gov/dsld/index.jsp
   Google Scholar